Forum on Drug Discovery, Development, and Translation

ספרים שבהם Forum on Drug Discovery, Development, and Translation מופיע/ה ברשימת המחברים, לא כמחבר/ת הראשי/ת: ספרים משותפים, אוספים וסיכומים.

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BricsSteve Olson

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the Brics

Steve Olson · 2014

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical ProductsDenise Caruso

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

Denise Caruso · 2014

Building a National Framework for the Establishment of Regulatory Science for Drug DevelopmentYeonwoo Lebovitz

Building a National Framework for the Establishment of Regulatory Science for Drug Development

Yeonwoo Lebovitz · 2011

Emerging Threat of Drug-Resistant Tuberculosis in Southern AfricaSteve Olson

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Steve Olson · 2011

Understanding the benefits and risks of pharmaceuticalsLeslie A. Pray

Understanding the benefits and risks of pharmaceuticals

Leslie A. Pray · 2007

Defining and Evaluating in-Home Drug Disposal Systems for Opioid AnalgesicsNational Academies of Sciences, Engineering, and Medicine

Defining and Evaluating in-Home Drug Disposal Systems for Opioid Analgesics

National Academies of Sciences, Engineering, and Medicine · 2024

Addressing Treatment Resistance in the Development of Cancer Immune Modulator TherapeuticsNational Academies of Sciences, Engineering, and Medicine

Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics

National Academies of Sciences, Engineering, and Medicine · 2024

Inclusion of Pregnant and Lactating Persons in Clinical TrialsNational Academies of Sciences, Engineering, and Medicine

Inclusion of Pregnant and Lactating Persons in Clinical Trials

National Academies of Sciences, Engineering, and Medicine · 2023

Envisioning a Transformed Clinical Trials Enterprise For 2030National Academies of Sciences, Engineering, and Medicine

Envisioning a Transformed Clinical Trials Enterprise For 2030

National Academies of Sciences, Engineering, and Medicine · 2022

Innovation in Drug Research and Development for Prevalent Chronic DiseasesNational Academies of Sciences, Engineering, and Medicine

Innovation in Drug Research and Development for Prevalent Chronic Diseases

National Academies of Sciences, Engineering, and Medicine · 2021

Examining the Impact of Real-World Evidence on Medical Product DevelopmentNational Academies of Sciences, Engineering, and Medicine

Examining the Impact of Real-World Evidence on Medical Product Development

National Academies of Sciences, Engineering, and Medicine · 2019

Virtual Clinical Trials : Challenges and OpportunitiesNational Academies of Sciences, Engineering, and Medicine

Virtual Clinical Trials : Challenges and Opportunities

National Academies of Sciences, Engineering, and Medicine · 2019